Boundless Bio, Inc. - Common Stock (BOLD)
1.5600
+0.3600 (30.00%)
NASDAQ · Last Trade: Apr 15th, 1:28 AM EDT
Let's have a look at the gap up and gap down stocks in today's session.
Via Chartmill · April 14, 2026

BOLD stock results show that Boundless Bio beat analyst estimates for earnings per share the second quarter of 2024.
Via InvestorPlace · August 12, 2024

Boundless Bio just reported results for the first quarter of 2024.
Via InvestorPlace · May 13, 2024

Shares of Boundless Bio fell almost 10% after raising about $100 million in the company's initial public offering. Bayer is one of the biggest investors for the therapeutics company.
Via Talk Markets · March 31, 2024